Rheumatoid Arthritis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Rheumatoid Arthritis stocks.

Rheumatoid Arthritis Stocks Recent News

Date Stock Title
Aug 1 GLPG Galapagos, BridGene expand agreement to develop small molecule oncology asset
Aug 1 GLPG Galapagos GAAP EPS of €1.51, revenue of €140.3M
Aug 1 GLPG Galapagos reports half-year 2024 financial results and provides second quarter business update
Aug 1 CHRS Coherus to Report Second Quarter 2024 Financial Results on August 8, 2024
Aug 1 PCRX Pacira BioSciences, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Jul 31 PCRX Pacira (PCRX) Q2 Earnings Beat, Exparel Sales Drive Revenues
Jul 31 RIGL Collegium Pharmaceutical (COLL) Soars 10.6%: Is Further Upside Left in the Stock?
Jul 31 PCRX Pacira BioSciences, Inc. (PCRX) Q2 2024 Earnings Call Transcript
Jul 31 MESO Appendix 4C Quarterly Activity Report for Quarter Ended June 30, 2024
Jul 30 PCRX Pacira: Q2 Earnings Snapshot
Jul 30 PCRX Pacira BioSciences Non-GAAP EPS of $0.89 beats by $0.19, revenue of $178M beats by $4.32M
Jul 30 PCRX Pacira BioSciences Reports Second Quarter 2024 Financial Results
Jul 30 RIGL Rigel Pharmaceuticals (RIGL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Jul 30 RIGL Rigel Announces Conference Call and Webcast to Report Second Quarter 2024 Financial Results and Business Update
Jul 30 IXHL Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X
Jul 30 CGEN Compugen receives FDA approval for Phase I trial of solid tumour treatment
Jul 29 PCRX Pacira BioSciences Q2 2024 Earnings Preview
Jul 29 CVM CEL-SCI Announces Closing of $10.8 Million Offering
Jul 29 MESO Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Jul 29 CGEN Compugen Announces FDA Clearance of IND for COM503 for the Treatment of Solid Tumors
Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a long-term autoimmune disorder that primarily affects joints. It typically results in warm, swollen, and painful joints. Pain and stiffness often worsen following rest. Most commonly, the wrist and hands are involved, with the same joints typically involved on both sides of the body. The disease may also affect other parts of the body. This may result in a low red blood cell count, inflammation around the lungs, and inflammation around the heart. Fever and low energy may also be present. Often, symptoms come on gradually over weeks to months.While the cause of rheumatoid arthritis is not clear, it is believed to involve a combination of genetic and environmental factors. The underlying mechanism involves the body's immune system attacking the joints. This results in inflammation and thickening of the joint capsule. It also affects the underlying bone and cartilage. The diagnosis is made mostly on the basis of a person's signs and symptoms. X-rays and laboratory testing may support a diagnosis or exclude other diseases with similar symptoms. Other diseases that may present similarly include systemic lupus erythematosus, psoriatic arthritis, and fibromyalgia among others.The goals of treatment are to reduce pain, decrease inflammation, and improve a person's overall functioning. This may be helped by balancing rest and exercise, the use of splints and braces, or the use of assistive devices. Pain medications, steroids, and NSAIDs are frequently used to help with symptoms. Disease-modifying antirheumatic drugs (DMARDs), such as hydroxychloroquine and methotrexate, may be used to try to slow the progression of disease. Biological DMARDs may be used when disease does not respond to other treatments. However, they may have a greater rate of adverse effects. Surgery to repair, replace, or fuse joints may help in certain situations. Most alternative medicine treatments are not supported by evidence.RA affects about 24.5 million people as of 2015. This is between 0.5 and 1% of adults in the developed world with 5 and 50 per 100,000 people newly developing the condition each year. Onset is most frequent during middle age and women are affected 2.5 times as frequently as men. In 2013, it resulted in 38,000 deaths up from 28,000 deaths in 1990. The first recognized description of RA was made in 1800 by Dr. Augustin Jacob Landré-Beauvais (1772–1840) of Paris. The term rheumatoid arthritis is based on the Greek for watery and inflamed joints.

Browse All Tags